GPR178 inhibitors pertain to a specialized class of chemical compounds designed to interact with the G protein-coupled receptor 178 (GPR178). The GPR178 is a member of a large protein family of receptors that respond to various extracellular stimuli and play a crucial role in cellular communication. The receptors in this family are characterized by their seven-transmembrane domain structure, which traverses the cellular membrane, allowing for the transmission of signals from outside the cell to its interior. The inhibitors targeting GPR178 are formulated to bind selectively to this receptor, affecting its natural function of signal transduction.
The development and characterization of GPR178 inhibitors involve an intricate understanding of the receptor's structure and the molecular interactions that occur upon ligand binding. By binding to the GPR178 receptor, these inhibitors can modulate the receptor's activity in a highly specific manner. The chemical entities that function as GPR178 inhibitors are often small molecules that have been optimized through various medicinal chemistry programs to achieve high affinity and selectivity for the receptor. The binding of these molecules to GPR178 affects the receptor's ability to engage with its associated G proteins, which are intracellular partners critical for the propagation of signals to downstream effectors within the cell. The precise mechanism by which GPR178 inhibitors exert their influence on the receptor involves a complex interplay of molecular events, often including conformational changes in the receptor that impede its interaction with other cellular components.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
A toxin that targets and inhibits Gi/o class of G-proteins. If GPR178 signals through Gi/o, pertussis toxin can inhibit its downstream signaling. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selective beta-adrenergic antagonist. By antagonizing related receptors, it can potentially affect GPR178 if they share common signaling pathways. | ||||||
Atropine | 51-55-8 | sc-252392 | 5 g | $204.00 | 2 | |
Antagonist for muscarinic acetylcholine receptors. If GPR178 has any overlap in signaling with muscarinic receptors, atropine can influence its activity. | ||||||
NF 023 | 104869-31-0 | sc-204124 sc-204124A | 10 mg 50 mg | $161.00 $629.00 | 1 | |
A selective inhibitor of Gα subunits. It can prevent activation of these subunits and thus potentially inhibit GPR178 if it signals through these subunits. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
cAMP synthesis inhibitor. If GPR178 signaling involves cAMP generation, this inhibitor can suppress its downstream effects. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Cdc42 GTPase inhibitor. If GPR178 signaling intersects with the Cdc42 pathway, ML141 can affect its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. If GPR178 activates the PI3K-Akt pathway, LY294002 can inhibit its downstream signaling. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
Inhibits phosphatidylcholine-specific phospholipase C. If GPR178 signaling is linked to this specific PLC, D609 can modulate its function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho-associated protein kinase (ROCK) inhibitor. If GPR178 signaling intersects with the Rho-ROCK pathway, Y-27632 can influence its effects. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
Protein kinase A inhibitor. If GPR178 signaling involves PKA activation, KT5720 can suppress its downstream signaling. | ||||||